The Cure Dilemma: Biotech’s Profit Puzzle in One-Shot Therapies
In the high-stakes world of biotechnology, where scientific breakthroughs promise to eradicate diseases, a provocative question lingers: Is curing patients a viable long-term bu...
Read More